Inventor · disambiguated record
Thomas Bugge
Also filed as: BUGGE THOMAS · BUGGE THOMAS H
6 granted patents·3 pending applications·12 citations·filing 2000–2016
75Inventor score
Files withUS HEALTH3US GOV HEALTH & HUMAN SERV2GOVERNMENT OF THE US SECRETARY1LEPPLA STEPHEN1LEPPLA STEPHEN H1
Top patents by PatentIndex Score
9 records- 0181US7947289B2Multimeric protein toxins to target cells having multiple identifying characteristicsUS HEALTH·Filed 2005·Granted May 24, 2011·6 cites·29 claims
- 0273US8388933B2Multimeric protein toxins to target cells having multiple identifying characteristicsLEPPLA STEPHEN H·Filed 2011·Granted Mar 5, 2013·3 cites·18 claims
- 0369US7468352B1Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptorsUS HEALTH·Filed 2000·Granted Dec 23, 2008·3 cites·17 claims
- 0458US9403872B2Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptorsTHE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2014·Granted Aug 2, 2016·0 cites·5 claims
- 0553US8791074B2Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptorsLEPPLA STEPHEN·Filed 2008·Granted Jul 29, 2014·0 cites·17 claims
- 0650US2008166375A1Activation of Recombinant Diphtheria Toxin Fusion Proteins by Specific Proteases Highly Expressed on the Surface of Tumor CellsUS GOV HEALTH & HUMAN SERV·Filed 2004·Application pending·0 cites
- 0748US2010168012A1Human cancer therapy using engineered matrix metalloproteinase-activated anthrax lethal toxin that targets tumor vasculatutureGOVERNMENT OF THE US SECRETARY·Filed 2007·Application pending·0 cites
- 0847US2005123476A1Imaging the activity of extracellular protease in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteasesUS GOV HEALTH & HUMAN SERV·Filed 2002·Application pending·0 cites
- 0938US10835593B2Modified anthrax toxin protective antigenUS HEALTH·Filed 2016·Granted Nov 17, 2020·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →